化合物CDN1163 T7373
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 892711-75-0 | ¥5,230.00 | 询底价 |
10 mg | 892711-75-0 | ¥987.00 | 询底价 |
2 mg | 892711-75-0 | ¥397.00 | 询底价 |
1 mL | 892711-75-0 | ¥688.00 | 询底价 |
50 mg | 892711-75-0 | ¥3,570.00 | 询底价 |
1 mg | 892711-75-0 | ¥289.00 | 询底价 |
5 mg | 892711-75-0 | ¥638.00 | 询底价 |
25 mg | 892711-75-0 | ¥1,980.00 | 询底价 |
Product Introduction
Bioactivity
英文名: CDN1163
描述: CDN1163 是肌膜/内质网 Ca2+-ATPase (SERCA)的变构激活剂,可改善 Ca2+稳态,可减轻糖尿病和代谢紊乱。
体内活性: CDN1163, which markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight in lean controls.?Importantly, CDN1163-treated ob/ob mice maintained euglycemia comparable with that of lean mice for >6 weeks after cessation of CDN1163 administration[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (156.06 mM)
关键字: Inhibitor | Calcium Channel | Ca channels | Ca2+ channels | CDN-1163 | CDN1163 | CDN 1163 | inhibit
相关产品: Mibefradil dihydrochloride | Calciseptin | Daurinoline | Cronidipine | Vatanidipine | Upacicalcet | ω-conotoxin MoVIA | SR33805 | Norverapamil hydrochloride | Palonidipine
相关库: Ion Channel Inhibitor Library | Mitochondria-Targeted Compound Library | Calcium Channel Compound Library | Anti-Cancer Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Metabolism Compound Library | Reprogramming Compound Library | Anti-Cardiovascular Disease Compound Library | Bioactive Compound Library
化合物CDN1163 T7373信息由TargetMol中国为您提供,如您想了解更多关于化合物CDN1163 T7373报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途